Bausch Health Companies Inc. (TSX:BHC)
Canada · Delayed Price · Currency is CAD 9.04
-0.30 (-3.21%)
Oct 6, 2025, 4:00 PM EDT
Bausch Health Companies Employees
Bausch Health Companies had 20,700 employees as of December 31, 2024. The number of employees increased by 430 or 2.12% compared to the previous year.
Employees
20,700
Change (1Y)
430
Growth (1Y)
2.12%
Revenue / Employee
649.51K CAD
Profits / Employee
6.46K CAD
Market Cap
3.45B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 20,700 | 430 | 2.12% |
| Dec 31, 2023 | 20,270 | 370 | 1.86% |
| Dec 31, 2022 | 19,900 | 300 | 1.53% |
| Dec 31, 2021 | 19,600 | -2,000 | -9.26% |
| Dec 31, 2020 | 21,600 | -100 | -0.46% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Curaleaf Holdings | 5,519 |
| Green Thumb Industries | 4,800 |
| Trulieve Cannabis | 6,000 |
| dentalcorp Holdings | 10,200 |
| Sienna Senior Living | 12,263 |
| WELL Health Technologies | 1,507 |
| Cronos Group | 459 |
| Extendicare | 23,000 |
Bausch Health Companies News
- 6 days ago - Bausch Health's Aesthetic Business, Solta Medical, Brings Non-Invasive Aesthetic Innovations to National TV - Accesswire
- 6 days ago - Bausch Health to Announce Third Quarter 2025 Results on October 29 - Accesswire
- 7 days ago - Bausch Health (BHC) Launches OraTalks Podcast to Address Dental Industry Issues - GuruFocus
- 7 days ago - Bausch Health's OraPharma Introduces "OraTalks," a New Podcast Bringing Bold Conversations to Dentistry - Accesswire
- 11 days ago - BHC Makes Notable Cross Below Critical Moving Average - Nasdaq
- 11 days ago - Bausch + Lomb Breaks Below 200-Day Moving Average - Notable for BLCO - Nasdaq
- 13 days ago - Bausch Health (BHC) and Teva Accused of Antitrust Violations Over Xifaxan - GuruFocus
- 25 days ago - Bausch Health: Repricing Continues As Deleveraging Gains Traction - Seeking Alpha